The Green Trial
There was drama. There was heartache. There were flights. But today, finally, Iām in a clinical trial.
In our last episode, I was counting down to my trip to the National Institute of Health in Bethesda, Maryland to screen for admission into a trial. However, my hemoglobin levels cratered. A blood transfusion helped a lot. But getting that bag of backup blood barred me from being able to screen for the trial for another 28 days. Three days before my trip, a staff member called and suggested I just stay home and re-schedule the trip for later. At that point, I had gone more than six weeks without any treatment, so hearing this was a real kick in the liver.
After conferring with my oncologist, and her conferring (fiercely, Iām going to guess) with NIH, I went ahead and made the trip anyway. NIH is huge. A sprawling complex that employs 20,000 people, it was also fortunate enough to be funded in September and avoid the government shutdown. Security is high and the number of people they process through their clinical center is impressive. The clinic I visited was on the 13th floor, because science laughs at your triskaidekaphobia.
Met an NIH oncologist who gave me new hope. A slot in a second trial I qualified for had opened. If I passed the analysis of my CT scan, I could start within a week. This drug was also an oral chemo with fewer documented side effects. It was also brand new. I would have been patient #3. While having less data made it riskier, I kind of liked that. If Iām going to become part of the Great Experiment of national cancer research, letās go big or go home. I headed back to Little Rock, ready to hear news two days later.
And the call came. From the outset, the oncologistās tone was very apologetic. The open slot in the new trial⦠was filled while he and I were meeting about it. Heartbreak. The one silver lining: this doc was now an advocate for me and wanted to find something else. And he did.
Tuesday, I came back to Bethesda and screened. All blood levels were good enough for this third trial. I was enrolled and am writing this from a hospital bed where Iām being kept for my first two doses. The drug is a āsister drugā of the last one I missed. Itās administered orally and this is the best way I can describe it.
All our cells have instruction book on how to cell. Oh, youāre a muscle cell? Hereās what you do as a muscle cell. When cancer attacks, it blocks the part of the cellās instruction book that tells it how to fight this space invader. In other words, the cancer deactivates the cellās ability to resist.
This experimental drug essentially goes to cells and says āHey, idiot, look at Chapter 12! You know how to fight this devil.ā It turns Charles Lee cells into Marquis de Lafayettes. As a re-activation drug, it should (please) be less harsh on my body than previous traditional chemo lines. Itās also very new, with fewer than 30 people signed up so far. Part of the trial is figuring out exactly how the drug does the voodoo it does.
And Iām ready for fewer side effects. The time without treatment (10 weeks) meant more pressure from tumor fluid on my GI tract and the inability to put weight on my suddenly too-skinny frame. Hopefully that changes soon. Of course, thereās no way to know, because this is, after all, an experiment. Science!
Iāll be back and forth to Maryland for a few days at a time, less frequently as the cycles go on, unless there are unexpected developments. Bethesda is the new front in the cancer war and it wonāt always have the 1Ė wind chill it had upon arrival. I didnāt order the cryo-therapy, thank you.
Here I lie reclined on the frontier of yet another Undiscovered Cancer Country. Even more than usual, no one knows what comes next. Iāll just keep betting with house money until the next thing happens.
Musically, TWO fight songs for the new trial. First, my favorite track from the all-around banginā Spider-Man: Into the Multiverse soundtrack. Then, since some readers have wanted more mainstream artists, some recent Imagine Dragons. Man, whatās it like to be in the mainstream? Itās been awhile.















